Eli Lilly Corp. buy The Goldman Sachs Group, Inc.
Start price
13.12.25
/
50%
€881.10
Target price
13.12.26
€975.54
Performance (%)
-9.61%
Price
30.04.26
€796.40
Summary
This prediction is currently active. With a performance of -9.61%, the BUY prediction by The_Goldman_Sachs_Gr is trending in the wrong direction. This prediction currently runs until 13.12.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 1.439% | 1.439% |
| iShares Core DAX® | 0.985% | 8.314% |
| iShares Nasdaq 100 | 2.067% | 16.765% |
| iShares Nikkei 225® | 2.270% | 15.605% |
| iShares S&P 500 | 1.043% | 11.077% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $951.00 to $1,145.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€719.00
12.10.25
12.10.25
€756.64
12.10.26
12.10.26
10.77%
30.04.26
30.04.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€678.00
08.04.25
08.04.25
€810.30
08.04.26
08.04.26
20.34%
09.04.26
09.04.26